Elicera Therapeutics AB Statistics
Total Valuation
STO:ELIC has a market cap or net worth of SEK 156.04 million. The enterprise value is 138.18 million.
| Market Cap | 156.04M |
| Enterprise Value | 138.18M |
Important Dates
The next confirmed earnings date is Tuesday, May 5, 2026.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:ELIC has 48.54 million shares outstanding. The number of shares has increased by 36.74% in one year.
| Current Share Class | 48.54M |
| Shares Outstanding | 48.54M |
| Shares Change (YoY) | +36.74% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 51.88% |
| Owned by Institutions (%) | 13.44% |
| Float | 20.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 21.09 |
| PS Ratio | 14.67 |
| PB Ratio | 8.53 |
| P/TBV Ratio | 8.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.56 |
| EV / Sales | 12.99 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.04
| Current Ratio | 8.04 |
| Quick Ratio | 8.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,195.06 |
Financial Efficiency
Return on equity (ROE) is -56.62% and return on invested capital (ROIC) is -36.71%.
| Return on Equity (ROE) | -56.62% |
| Return on Assets (ROA) | -27.85% |
| Return on Invested Capital (ROIC) | -36.71% |
| Return on Capital Employed (ROCE) | -81.92% |
| Weighted Average Cost of Capital (WACC) | 7.25% |
| Revenue Per Employee | 3.55M |
| Profits Per Employee | -4.82M |
| Employee Count | 2 |
| Asset Turnover | 0.32 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.90% in the last 52 weeks. The beta is 0.55, so STO:ELIC's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | -26.90% |
| 50-Day Moving Average | 5.37 |
| 200-Day Moving Average | 5.77 |
| Relative Strength Index (RSI) | 19.56 |
| Average Volume (20 Days) | 182,311 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:ELIC had revenue of SEK 10.64 million and -14.45 million in losses. Loss per share was -0.30.
| Revenue | 10.64M |
| Gross Profit | 10.64M |
| Operating Income | -14.99M |
| Pretax Income | -14.45M |
| Net Income | -14.45M |
| EBITDA | n/a |
| EBIT | -14.99M |
| Loss Per Share | -0.30 |
Balance Sheet
The company has 17.86 million in cash and n/a in debt, giving a net cash position of 17.86 million or 0.37 per share.
| Cash & Cash Equivalents | 17.86M |
| Total Debt | n/a |
| Net Cash | 17.86M |
| Net Cash Per Share | 0.37 |
| Equity (Book Value) | 18.30M |
| Book Value Per Share | 0.38 |
| Working Capital | 18.30M |
Cash Flow
| Operating Cash Flow | -27.79M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -140.95% and -135.89%.
| Gross Margin | 100.00% |
| Operating Margin | -140.95% |
| Pretax Margin | -135.89% |
| Profit Margin | -135.89% |
| EBITDA Margin | n/a |
| EBIT Margin | -140.95% |
| FCF Margin | n/a |
Dividends & Yields
STO:ELIC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -36.74% |
| Shareholder Yield | -36.74% |
| Earnings Yield | -9.26% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
STO:ELIC has an Altman Z-Score of 61.67 and a Piotroski F-Score of 2.
| Altman Z-Score | 61.67 |
| Piotroski F-Score | 2 |